These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 32151220
1. Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery. Zhao K, Zhang Y, Li J, Cui Q, Zhao R, Chen W, Liu J, Zhao B, Wan Y, Ma XL, Yu S, Yi D, Gao F. J Am Heart Assoc; 2020 Mar 17; 9(6):e012376. PubMed ID: 32151220 [Abstract] [Full Text] [Related]
2. Myocardial Protection by Glucose-Insulin-Potassium in Moderate- to High-Risk Patients Undergoing Elective On-Pump Cardiac Surgery: A Randomized Controlled Trial. Ellenberger C, Sologashvili T, Kreienbühl L, Cikirikcioglu M, Diaper J, Licker M. Anesth Analg; 2018 Apr 17; 126(4):1133-1141. PubMed ID: 29324494 [Abstract] [Full Text] [Related]
3. Cardioprotective Effects of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis. Hagerman A, Schorer R, Putzu A, Keli-Barcelos G, Licker M. Semin Thorac Cardiovasc Surg; 2018 Apr 17; 36(2):167-181. PubMed ID: 36356908 [Abstract] [Full Text] [Related]
4. Glucosa-Insulin-Potassium (GIK) solution used with diabetic patients provides better recovery after coronary bypass operations. Straus S, Gerc V, Kacila M, Faruk C. Med Arch; 2013 Apr 17; 67(2):84-7. PubMed ID: 24341049 [Abstract] [Full Text] [Related]
5. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Ranasinghe AM, Quinn DW, Pagano D, Edwards N, Faroqui M, Graham TR, Keogh BE, Mascaro J, Riddington DW, Rooney SJ, Townend JN, Wilson IC, Bonser RS. Circulation; 2006 Jul 04; 114(1 Suppl):I245-50. PubMed ID: 16820580 [Abstract] [Full Text] [Related]
6. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. Lell WA, Nielsen VG, McGiffin DC, Schmidt FE, Kirklin JK, Stanley AW. Ann Thorac Surg; 2002 Apr 04; 73(4):1246-51; discussion 1251-2. PubMed ID: 11998815 [Abstract] [Full Text] [Related]
13. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction. Díaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S. JAMA; 2007 Nov 28; 298(20):2399-405. PubMed ID: 18042917 [Abstract] [Full Text] [Related]
14. Glucose-insulin-potassium therapy in patients with acute coronary syndrome: a meta-analysis of randomized controlled trials. Jin PY, Zhang HS, Guo XY, Liang WF, Han QF. BMC Cardiovasc Disord; 2014 Nov 25; 14():169. PubMed ID: 25425404 [Abstract] [Full Text] [Related]
15. Intravenous glucose-insulin-potassium during off-pump coronary artery bypass surgery does not reduce myocardial injury. Shim YH, Kweon TD, Lee JH, Nam SB, Kwak YL. Acta Anaesthesiol Scand; 2006 Sep 25; 50(8):954-61. PubMed ID: 16923090 [Abstract] [Full Text] [Related]